EGFR was chosen as a candidate gene because EGFR polymorphisms and mutations have been associated with a number of cancers, including anal cancer [28], colorectal cancer [29], glioblastoma [30], and non-small-cell lung cancer [13,16]. Here, EGFR is linked to cancer.